Editorial: Pleiotropism of adiponectin: Inflammation, neovascularization, and fibrosis

Circulation Research

Volumn 104, Issue 9, 2009, Pages 1029-1031

  Krenning, Guido ^a   Moonen, Jan Renier A J ^a   Harmsen, Martin C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adipokines; Adiponectin; Fibrosis; Inflammation; Neovascularization

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSIN II ANTAGONIST; ANGIOTENSINOGEN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLITAZONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN, HUMAN; ADIPONECTIN, MOUSE;

CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL INTERACTION; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETIC RETINOPATHY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; FIBROSIS; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OBESITY; PLEIOTROPY; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINITIS; VASCULITIS; ANIMAL; METABOLISM; MOUSE; NOTE; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; DIABETIC RETINOPATHY; FIBROSIS; HUMANS; INFLAMMATION; MICE; OBESITY; RETINAL NEOVASCULARIZATION; SIGNAL TRANSDUCTION;

EID: 66149129163     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.198044     Document Type: Editorial

References (27)

1. Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53:S35-S42.
2. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2005;438:960-966.
3. Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30:65-84.
4. Bulcao C, Ferreira SR, Giuffrida FM, Ribeiro-Filho FF. The new adipose tissue and adipocytokines. Curr Diabetes Rev. 2006;2:19-28.
5. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003; 14:561-566.
6. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257:79-83.
7. Higuchi A, Ohashi K, Kihara S, Walsh K, Ouchi N. Adiponectin suppresses pathological microvessel formation in retina through modulation of Tumor Necrosis Factor-a expression. Circ Res. 2009;104:1058-1065.
8. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2004;279:1304-1309. (Pubitemid 38082655)
9. Cacicedo JM, Yagihashi N, Keaney JF Jr, Ruderman NB, Ido Y. AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2004;324:1204-1209.
10. Park PH, Huang H, McMullen MR, Bryan K, Nagy LE. Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages. J Leukoc Biol. 2008;83:1258-1266.
11. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 1995;270:9558-9563.
12. Hickey MJ, Issekutz AC, Reinhardt PH, Fedorak RN, Kubes P. Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-en-dothelial cell interactions, and microvascular permeability during endo-toxemia. Circ Res. 1998;83:1124-1131.
13. Masaie H, Oritani K, Yokota T, Takahashi I, Shirogane T, Ujiie H, Ichii M, Saitoh N, Maeda T, Tanigawa R, Oka K, Hoshida Y, Tomiyama Y, Kanakura Y. Adiponectin binds to chemokines via the globular head and modulates interactions between chemokines and heparan sulfates. Exp Hematol. 2007;35:947-956.
14. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem. 2005;280: 18341-18347.
15. Krenning G, van Luyn MJA, Harmsen MC. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med. 2009;15:180-189.
16. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712.
17. Werner N, Nickenig G. Influence of cardiovascular risk factors on endo-thelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol. 2006;26:257-266.
18. Shibata R, Skurk C, Ouchi N, Galasso G, Kondo K, Ohashi T, Shimano M, Kihara S, Murohara T, Walsh K. Adiponectin promotes endothelial progenitor cell number and function. FEBS Lett. 2008;582:1607-1612.
19. Koh KK, Quon MJ, Han SH, Ahn JY, Jin DK, Kim HS, Kim DS, Shin EK. Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes. Hypertension. 2005;45: 1088-1093.
20. Tsunekawa T, Hayashi T, Suzuki Y, Matsui-Hirai H, Kano H, Fukatsu A, Nomura N, Miyazaki A, Iguchi A. Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. Diabetes Care. 2003;26:285-289.
21. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y. An adipocyte-derived plasma protein, adi-ponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32: 47-50.
22. Krenning G, Moonen JRAJ, van Luyn MJA, Harmsen MC. Generating new blood flow: integrating developmental biology and tissue engineering. Trends Cardiovasc Med. 2008;18:314-324.
23. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, Fukui K, Maeda N, Nishizawa H, Nagaretani H, Okamoto Y, Kihara S, Miyagawa J, Shinomura Y, Funahashi T, Matsuzawa Y. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology. 2003; 125:1796-1807.
24. Yoda-Murakami M, Taniguchi M, Takahashi K, Kawamata S, Saito K, Choi-Miura NH, Tomita M. Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver. Biochem Biophys Res Commun. 2001;285:372-377.
25. Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, Nishida M, Hiuge A, Kurata A, Kihara S, Shimomura I, Funahashi T. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler Thromb Vasc Biol. 2008; 28:863-870.
26. Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, Yorioka N. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest. 2009;89:47-58.
27. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Navab M, Reddy ST, Buga GM, Fogelman AM. Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep. 2009;11:52-57.